Study Evaluating Venetoclax in Subjects With Hematological Malignancies

Clinical trial NCT02265731 · COMPLETED

Trial details

NCT number: NCT02265731
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma (NHL)Multiple Myeloma (MM)Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)Acute Myeloid Leukemia (AML)

Start date: 2014-09-22
Primary completion: 2021-03-12
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.